{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:46Z","timestamp":1759334866692,"version":"build-2065373602"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jaad.2014.01.883","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T13:38:40Z","timestamp":1407937120000},"page":"581-582.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Topical antimicrobial acne treatment tolerability: A\u00a0meaningful factor in treatment adherence?"],"prefix":"10.1016","volume":"71","author":[{"given":"Kyle B.","family":"Bartlett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.01.883_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2340\/00015555-0073","article-title":"To follow or not to follow dermatological treatment\u2013a review of the literature","volume":"86","author":"Serup","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2014.01.883_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaad.2008.11.019","article-title":"An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris","volume":"60","author":"Yentzer","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000017851","article-title":"Why and when the treatment of acne fails. what to do","volume":"196","author":"Katsambas","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.01.883_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0149-2918(02)80023-6","article-title":"A randomized, double-blind comparison of a clindamycin phosphate\/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris","volume":"24","author":"Cunliffe","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2014.01.883_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1346-8138.2011.01405.x","article-title":"Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris","volume":"39","author":"Akarsu","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0149-2918(02)80073-X","article-title":"Preliminary results of a nonrandomized, multicenter, open-label study of patient satisfaction after treatment with combination benzoyl peroxide\/clindamycin topical gel for mild to moderate acne","volume":"24","author":"Weiss","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2014.01.883_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00128071-200102010-00006","article-title":"Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with\u00a0benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib8","first-page":"736","article-title":"Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations","volume":"8","author":"Webster","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib9","first-page":"1382","article-title":"Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: A phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study","volume":"10","author":"Eichenfield","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib10","first-page":"634","article-title":"The development and optimization of a fixed combination of clindamycin and benzoyl peroxide aqueous gel","volume":"8","author":"Bucks","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jocd.12013","article-title":"The tolerability profile of clindamycin 1%\/benzoyl peroxide 5% gel vs. adapalene 0.1%\/benzoyl peroxide 2.5% gel for facial acne: Results of a randomized, single-blind, split-face study","volume":"11","author":"Gonzalez","year":"2012","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-3083.2008.02920.x","article-title":"Prospective, open-label, comparative study of clindamycin 1%\/benzoyl peroxide 5% gel with adapalene 0.1% gel in asian acne patients: Efficacy and tolerability","volume":"23","author":"Ko","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.01.883_bib13","first-page":"16","article-title":"The tolerability profile of clindamycin 1%\/Benzoyl peroxide 5% gel vs. adapalene 0.1%\/Benzoyl peroxide 2.5% gel for facial acne: Results of two randomized, single-blind, split-face studies","volume":"5","author":"Green","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients","volume":"59","author":"Thiboutot","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib15","first-page":"818","article-title":"Moderate to severe acne in\u00a0adolescents with skin of color: Benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel","volume":"11","author":"Eichenfield","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2014.01.883_bib16","first-page":"643","article-title":"Fitzpatrick skin types and clindamycin phosphate 1.2%\/benzoyl peroxide gel: Efficacy and tolerability of treatment in moderate to severe acne","volume":"11","author":"Callender","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib17","first-page":"455","article-title":"Treatment of moderate to severe acne vulgaris in a hispanic population: A post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%\/benzoyl peroxide 2.5% gel","volume":"11","author":"Cook-Bolden","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib18","first-page":"1440","article-title":"Gender as a clinically relevant outcome variable in acne: Benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel","volume":"11","author":"Harper","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4103\/0253-7613.89815","article-title":"Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial","volume":"43","author":"Choudhury","year":"2011","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2014.01.883_bib20","first-page":"16","article-title":"Efficacy and tolerability of a three-step acne system containing a solubilized benzoyl peroxide lotion versus a benzoyl Peroxide\/Clindamycin combination product: An investigator-blind, randomized, parallel-group study","volume":"1","author":"Green","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0149-2918(02)85151-7","article-title":"A\u00a0randomized, parallel, vehicle-controlled comparison of two\u00a0erythromycin\/benzoyl peroxide preparations for acne vulgaris","volume":"24","author":"Thiboutot","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2014.01.883_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/120347540100500109","article-title":"The\u00a0efficacy and safety of a combination benzoyl peroxide\/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide\/erythromycin combination product","volume":"5","author":"Leyden","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2014.01.883_bib23","first-page":"259","article-title":"Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne","volume":"12","author":"Kircik","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib24","first-page":"442","article-title":"A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris","volume":"5","author":"Gold","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/030079903125001523","article-title":"Efficacy and safety of stabilised hydrogen peroxide cream (crystacide) in mild-to-moderate acne vulgaris: A randomised, controlled trial versus benzoyl peroxide gel","volume":"19","author":"Milani","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2014.01.883_bib26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2133.2005.07047.x","article-title":"Conjoint analysis: A novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial","volume":"154","author":"Kellett","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib27","first-page":"152","article-title":"Efficacy and tolerability of fixed-combination acne treatment in adolescents","volume":"91","author":"Gold","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2014.01.883_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1468-3083.2007.02398.x","article-title":"Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris","volume":"22","author":"Touitou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.01.883_bib29","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF02850194","article-title":"Clindamycin phosphate 1% gel in acne vulgaris","volume":"18","author":"Rizer","year":"2001","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2014.01.883_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/09546630260199460","article-title":"Clinical evaluation of double strength isotrexin versus benzamycin in the topical treatment of mild to moderate acne vulgaris","volume":"13","author":"Marazzi","year":"2002","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2014.01.883_bib31","doi-asserted-by":"crossref","DOI":"10.3310\/hta9010","article-title":"Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne","volume":"9","author":"Ozolins","year":"2005","journal-title":"Health Technol Asses"},{"key":"10.1016\/j.jaad.2014.01.883_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1365-2230.1994.tb01170.x","article-title":"Evaluation of 0.75% metronidazole gel in acne\u2013a double-blind study","volume":"19","author":"Tong","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib33","first-page":"1417","article-title":"The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: Gender as a clinically relevant outcome variable","volume":"11","author":"Tanghetti","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib34","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1468-3083.2006.01914.x","article-title":"Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne","volume":"21","author":"Stinco","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2014.01.883_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1473-2165.2011.00572.x","article-title":"A 10% glycolic acid containing oil-in-water emulsion improves mild acne: A randomized double-blind placebo-controlled trial","volume":"10","author":"Abels","year":"2011","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2230.2011.04214.x","article-title":"Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents","volume":"37","author":"Wilhelm","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib37","first-page":"223","article-title":"Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris","volume":"84","author":"Zouboulis","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2014.01.883_bib38","first-page":"s2","article-title":"Emerging topical antimicrobial options for mild-to-moderate acne: A review of the clinical evidence","volume":"7","author":"Del Rosso","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archdermatol.2008.562","article-title":"Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses","volume":"145","author":"Yentzer","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib40","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1046\/j.1365-2133.2000.03473.x","article-title":"Topical corticosteroid phobia in patients with atopic eczema","volume":"142","author":"Charman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1540-9740.2003.02037.x","article-title":"How do you foster medication adherence for better acne vulgaris management?","volume":"2","author":"Koo","year":"2003","journal-title":"Skinmed"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2014.01.883_bib42","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3109\/09546639809160542","article-title":"Better quality treatments for your patients","volume":"9","author":"Finlay","year":"1998","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2014.01.883_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000017972","article-title":"Evaluation of topical drug treatment in psoriasis","volume":"197","author":"van de Kerkhof","year":"1998","journal-title":"Dermatology"},{"year":"1987","author":"Melchenbaum","series-title":"Facilitating treatment adherence: A\u00a0practitioner's guidebook","key":"10.1016\/j.jaad.2014.01.883_bib44"},{"key":"10.1016\/j.jaad.2014.01.883_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00128071-200809050-00005","article-title":"Comparative irritation potential of two combination acne products: A randomized controlled, subject- and evaluator-blind, comparative study in healthy volunteers","volume":"9","author":"Dosik","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib46","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00128071-200203050-00007","article-title":"Clindamycin\/benzoyl peroxide gel: A\u00a0review of its use in the management of acne","volume":"3","author":"Warner","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib47","first-page":"48","article-title":"The role of benzoyl peroxide in the management of acne vulgaris","volume":"279","author":"Tucker","year":"2007","journal-title":"Pharm J"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2014.01.883_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1525-1470.2008.00667.x","article-title":"Practical considerations in acne treatment and the clinical impact of topical combination therapy","volume":"25","author":"Krakowski","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib49","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1610-0387.2006.06110.x","article-title":"Acne vulgaris\u2013psychosomatic aspects","volume":"4","author":"Niemeier","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2014.01.883_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2007.08308.x","article-title":"A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris","volume":"158","author":"Langner","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.138.3.337","article-title":"Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance","volume":"138","author":"Renzi","year":"2002","journal-title":"Arch Dermatol"},{"issue":"Suppl 52","key":"10.1016\/j.jaad.2014.01.883_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2133.1998.1390s2034.x","article-title":"Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations","volume":"139","author":"Galvin","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2014.01.883_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.5.6.665","article-title":"Novel vesicular and particulate drug delivery systems for topical treatment of acne","volume":"5","author":"Castro","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.jaad.2014.01.883_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/156720110793360612","article-title":"Topical dermatological drug delivery: Quo vadis?","volume":"7","author":"Akomeah","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.jaad.2014.01.883_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000089138","article-title":"Novel drug delivery systems: Potential in improving topical delivery of antiacne agents","volume":"19","author":"Date","year":"2006","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.jaad.2014.01.883_bib57","first-page":"969","article-title":"The characteristics and utility of solid phase porous microspheres: A review","volume":"5","author":"Smith","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib58","first-page":"28","article-title":"Microporous entrapment polymers offer new options for formulators","author":"Disapio","year":"1999","journal-title":"Global Cosmetic Industry"},{"issue":"Suppl 5","key":"10.1016\/j.jaad.2014.01.883_bib59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: An update from the global alliance to improve outcomes in acne group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib60","first-page":"256","article-title":"Tazarotene versus tazarotene plus clindamycin\/benzoyl peroxide in the treatment of acne vulgaris: A multicenter, double-blind, randomized parallel-group trial","volume":"5","author":"Tanghetti","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2014.01.883_bib61","first-page":"275","article-title":"Facilitating facial retinization through barrier improvement","volume":"78","author":"Draelos","year":"2006","journal-title":"Cutis"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2014.01.883_bib62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1396-0296.2004.04S1003.x","article-title":"Role of mild cleansing in the management of patient skin","volume":"17","author":"Subramanyan","year":"2004","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214010147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214010147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:52Z","timestamp":1759271452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214010147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0190962214010147"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.01.883","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical antimicrobial acne treatment tolerability: A\u00a0meaningful factor in treatment adherence?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.01.883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}